Regístrese gratis y obtenga acceso ilimitado a nuestra extensa biblioteca de elearning
Gane puntos CME y realice un seguimiento de su actividad de aprendizaje con cientos de horas de educación médica continua.
Compartir :

Breast Cancer CDK 4/6 Inhibitors - Module for Nurses

This module is suitable for nurses interested in the latest developments and research in breast cancer.

This course is a collection of modules on breast cancer CDK 4/6 inhibition, developed to support the professional development of three distinct healthcare professions. The content is based on the presentations that were given during the Coming of Age for CDK 4/6 Inhibitors industry satellite symposium held at the ESMO 2016 conference in Copenhagen, Denmark. The objective of this satellite symposium was to establish and deliver a globally leading educational initiative that has a significant impact on clinical practice.

Published August 2017.

Breast Cancer CDK 4/6 Inhibitors - Module for Nurses
0 CME Points

Público destinatarios

This module is designed to support the professional development of nurses.

Objetivos educativos

By the end of this module, you should be able to:

  • Explain the clinical benefit of CDK 4/6 inhibitors.
  • Learn how to manage the side effects of CDK4/6 inhibitors.
  • Be aware of adverse events and challenges.
  • Share your knowledge with your oncology team and your patients.

Requisitos del sistema

This module requires the learner to have a good, stable internet connection and can run on Internet Explorer 7 and above, Mozilla Firefox, Google Chrome and Opera on either Windows or MacOS. Flash Add-on is also required to run this module.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact and we will get back to you as soon as possible.

Política de divulgación

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.


Production of this module was funded by an unrestricted grant from Pfizer.